Co-administered drugs

Co-administered drugs refers to the practice of giving two or more drugs simultaneously or within a short time frame to achieve a clinical goal such as enhanced efficacy or mitigation of adverse effects. This can be intentional (e.g., cancer chemotherapy regimens using multiple cytotoxic agents for synergy) or incidental (e.g., polypharmacy in chronic disease management). Co-administration is not itself a biological molecule or target but rather a descriptor for therapeutic strategy. The main clinical considerations center around potential drug-drug interactions, which can be pharmacodynamic (additive, synergistic, or antagonistic effects) or pharmacokinetic (altered absorption, distribution, metabolism, or excretion). Evaluating and managing risks associated with co-administered drugs is a key aspect of clinical pharmacology and patient safety[1][2][4][5][7].

Other names

Combination therapyPolypharmacyCombined therapyConcomitant drugs